Stock Ratings / Health Care / INSP / forecast

LMAT (74) XRAY (46) UFPT (81) KMTS (43) ⌘ Pro Terminal →

Inspire Medical Systems Inc. (INSP) 12-Month Stock Forecast & Price Target Cone

$71.18 +0.30% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Inspire Medical Systems Inc. (INSP) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C- • HOLD / WATCH Cap $2.06B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+1.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for INSP)Realized 20D OHLCV Swing Band: ±8%

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your INSP Position Size: $10,000

Shares at $71.18: 140.5 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $56.27

$7,905

$-2,095 (-20.9%)

12M Consensus BaseTarget $72.14

$10,135

+$135 (+1.3%)

12M Bull Case BreakoutTarget $154.38

$21,689

+$11,689 (+116.9%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$75	74%	A
Goldman SachsSector Coverage Lead	BUY	$145	69%	B
JP MorganUS Large-Cap Research	HOLD	$64	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (INSP Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

INSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +26.79%🛡️ HOLDING TREND SUPPORT

2026-10-30O $70.63H $71.19L $67.80C $71.18VOL 796.4K

RES: $90.60SUP: $70.06SMA50: $68.59SMA200: $58.57

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

INSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 INSP Butterfly Map → + Track INSP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

6.0%/yr Implied 5Y Growth

vs. +13.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on INSP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for INSP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for INSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (INSP)

Health Care Rank #183 of 1016 ⚔️ LMAT vs INSP Full Matrix →

1. Head-to-Head Health Care Peer Comparison (INSP vs. LMAT, XRAY, UFPT, KMTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Inspire Medical Systems Inc. (INSP) ranks #183 by composite RQD confidence (61/100, grade C-) and #256 by equity capitalization ($2.06B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently holds the highest overall quantitative score in the immediate peer group at 81/100 (A-) compared with INSP at 61/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
INSP ACTIVE Inspire Medical Systems Inc.	C-	61/100	14.2x	85.4%	6.0%	+0.30%	$2.06B	Benchmark Subject
LMAT LeMaitre Vascular Inc.	B	74/100	33.8x	71.5%	14.7%	+2.90%	$1.95B	/lmat-vs-insp →
XRAY DENTSPLY SIRONA Inc.	D	46/100	—	50.0%	-11.0%	+1.80%	$1.92B	/xray-vs-insp →
UFPT UFP Technologies Inc.	A-	81/100	33.3x	28.3%	13.9%	+2.55%	$2.27B	/ufpt-vs-insp →
KMTS Kestra Medical Technologies Ltd.	D-	43/100	—	51.4%	-35.0%	+2.48%	$1.82B	/kmts-vs-insp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001609550

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Inspire Medical Systems Inc. (INSP) reported GAAP revenue of $912.0M (+13.6% vs. FY2024 revenue of $802.8M , and +46.0% cumulative change since FY2023) , GAAP net income of $145.4M, operating cash flow of $117.0M, and free cash flow of $78.5M (-13.9% YoY). On the balance sheet, INSP closed FY2025 with $907.3M in total assets against $0 in total debt (Altman Z-Score: 11.40, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$912.0M	$145.4M	$117.0M	$78.5M	$907.3M	—
FY2024 (FY)	2024-12-31	$802.8M	$53.5M	$130.2M	$91.1M	$808.4M	—
FY2023 (FY)	2023-12-31	$624.8M	-$21.2M	$24.7M	$24.7M	—	—

3. INSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is INSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Inspire Medical Systems Inc. (NYSE: INSP) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $71.18 (+0.30% 1D, market cap $2.06B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, INSP ranks #183 in composite RQD confidence.

How does INSP compare to LMAT and XRAY in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), INSP carries a Roarable C- (61/100 RQD), trailing P/E of 14.2x, gross margin of 85.4%, and ROIC of 6.0%. By comparison, LMAT (LeMaitre Vascular Inc.) holds a B grade (74/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B) and XRAY (DENTSPLY SIRONA Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for INSP?

Per INSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001609550), Inspire Medical Systems Inc. generated $912.0M in revenue (+13.6% YoY), $145.4M in net income, and $78.5M in free cash flow against $907.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is INSP trading relative to its 50-day, 200-day, and 52-week technical levels?

INSP last traded at $71.18 (+0.30% on volume of 512,603 shares), positioning the stock +3.78% above its 50-day simple moving average ($68.59) and +21.53% above its 200-day simple moving average ($58.57). Across its 52-week range of $38.91 to $147.03, INSP sits at the 29.8% percentile with a 14-day RSI of 45.4 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($65.49 to $76.87).

INSP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is INSP's 12-month stock price target?

Inspire Medical Systems Inc. (INSP) carries a 12-month consensus base price target of $72.14 (+1.3% from $71.18), with a bull-case target of $154.38 and a bear-case floor of $56.27.

Is INSP stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates INSP C- (Hold — HOLD) with an RQD Confidence score of 61/100.

Direct Sub-Reports: INSP RQD Cockpit INSP 12M Forecast INSP Earnings & Move INSP Dividends & DRIP INSP Insiders & 13F INSP Whale Options INSP Profit Sankey INSP News & Why